PROMEDIUS
Story

We are on a mission
to redefine the way we age.

Mission
Healthy Aging through AI

At PROMEDIUS, we are on a mission to redefine the way we age. Our cutting-edge AI technologies are dedicated to enhancing the quality of life and extending the healthy lifespan of individuals.We believe that aging should not be a relentless march toward decline but a journey filled with vitality and well-being.

Leadership

Hyun-Jin Bae Ph.D

CEO, Co-founder

- Post-doc, Asan Medical Center - Research Fellow, University of Ulsan - Carnegie Institute for Science - Ph.D., Yonsei University

Hyun-Jin Bae Ph.D

CEO, Co-founder

- Post-doc, Asan Medical Center - Research Fellow, University of Ulsan - Carnegie Institute for Science - Ph.D., Yonsei University

Hyun-Seok Kim

Head of Product

- Product Group Head, Hutom - Team Leader of Imaging Planning, Osstem Implant - MBA, Kookmin University - B.E., Myongji University

Hyun-Seok Kim

Head of Product

- Product Group Head, Hutom - Team Leader of Imaging Planning, Osstem Implant - MBA, Kookmin University - B.E., Myongji University

Dick She

Global Business I Director

- Product Marketing Manager, GE Healthcare - Upstream PM, Carestream - Business Manager, Genesis - Senior Marketing Manager, Hologic - M.E., Tianjin University - B.E., Beijing University of Technology

Dick She

Global Business I Director

- Product Marketing Manager, GE Healthcare - Upstream PM, Carestream - Business Manager, Genesis - Senior Marketing Manager, Hologic - M.E., Tianjin University - B.E., Beijing University of Technology

Minjee Kim

AI Research I Team Lead

- Researcher, Asan Medical Center - M.S., University of Ulsan - B.S., Seoul National University of Science and Technology

Minjee Kim

AI Research I Team Lead

- Researcher, Asan Medical Center - M.S., University of Ulsan - B.S., Seoul National University of Science and Technology

Hong-Jae Kim

Development I Team Lead

- S/W engineer, Vatech & Osstem Implant - M.S., Medical Image Science, Inje University

Hong-Jae Kim

Development I Team Lead

- S/W engineer, Vatech & Osstem Implant - M.S., Medical Image Science, Inje University

Eric Hyunsik Park

Marketing I Team Lead

- Product & Clinical Marketing Manager, Lunit - Overseas Sales Area Manager, Samsung Medison - B.A., Japanese & International Studies, Kyunghee University

Eric Hyunsik Park

Marketing I Team Lead

- Product & Clinical Marketing Manager, Lunit - Overseas Sales Area Manager, Samsung Medison - B.A., Japanese & International Studies, Kyunghee University

Byungyong Choi

Korea Business I Team Lead

- Manager of Korea Sales, AITRICS - Manager of Korea Business Development, Lunit - Tertiary Hospital Sales Manager, Hanmi Science - B.S., Control and Instrumentation Engineering, Korea University

Byungyong Choi

Korea Business I Team Lead

- Manager of Korea Sales, AITRICS - Manager of Korea Business Development, Lunit - Tertiary Hospital Sales Manager, Hanmi Science - B.S., Control and Instrumentation Engineering, Korea University

Sang-Joon Park

Corporate Planning I Team Lead

- Director of Financial Management Team, Remedi - Team Leader of Accounting Team, MD Healthcare - Team leader of Financial Management Team, Life Science Technology - Team leader of Accounting Team, DongKoo Bio&pharma - BABA, Kyonggi University

Sang-Joon Park

Corporate Planning I Team Lead

- Director of Financial Management Team, Remedi - Team Leader of Accounting Team, MD Healthcare - Team leader of Financial Management Team, Life Science Technology - Team leader of Accounting Team, DongKoo Bio&pharma - BABA, Kyonggi University

Kwangmin Woo

Branding I Team Lead

- Team leader of Exerience Strategy, Algocare - Brand Marketer, Riiid - Brand Marketer, millie - Brand Marketer, WINIA - Campaign Director, Trinity - B.A., Yonsei University (Mirae)

Kwangmin Woo

Branding I Team Lead

- Team leader of Exerience Strategy, Algocare - Brand Marketer, Riiid - Brand Marketer, millie - Brand Marketer, WINIA - Campaign Director, Trinity - B.A., Yonsei University (Mirae)

Journey Soyeon Jin

CEO Office I Team Lead

- Global Business Development Manager, Mediwhale - B.B.A., Pusan National University

Journey Soyeon Jin

CEO Office I Team Lead

- Global Business Development Manager, Mediwhale - B.B.A., Pusan National University

Co-founders

Joon Beom Seo, M.D., Ph.D.

Co-founder, Chief Medical Officer

- Post-doc, Asan Medical Center - Research Fellow, University of Ulsan - Carnegie Institute for Science - Ph.D., Yonsei University

Joon Beom Seo, M.D., Ph.D.

Co-founder, Chief Medical Officer

- Post-doc, Asan Medical Center - Research Fellow, University of Ulsan - Carnegie Institute for Science - Ph.D., Yonsei University

Namkug Kim, Ph.D.

Co-founder, Chief Strategy Officer

- Ph.D. in Industrial Engineering, Seoul National Univ. - Professor at Dept. of Convergence - Medicine, Asan Medical Center - Vice President, Korean Society of Artifical Intelligence in Medicine

Namkug Kim, Ph.D.

Co-founder, Chief Strategy Officer

- Ph.D. in Industrial Engineering, Seoul National Univ. - Professor at Dept. of Convergence - Medicine, Asan Medical Center - Vice President, Korean Society of Artifical Intelligence in Medicine

Jong Chul Ye, Ph.D.

Co-founder, Scientific Advisor

- Kim Jaechul Graduate School of AI, KAIST - KAIST Endowed Chaire Professor - President, Korean Society of Artificial Intelligence in Medicine

Jong Chul Ye, Ph.D.

Co-founder, Scientific Advisor

- Kim Jaechul Graduate School of AI, KAIST - KAIST Endowed Chaire Professor - President, Korean Society of Artificial Intelligence in Medicine

Advisors

Jean-Yves Reginster, M.D., Ph.D.

- Co-Founder and Board member of the International Osteoporosis Foundation (IOF) - Director of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging - President of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) - Director of the Department of Public Health, Epidemiology and Health Economics at the University of Liège

Jean-Yves Reginster, M.D., Ph.D.

- Co-Founder and Board member of the International Osteoporosis Foundation (IOF) - Director of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging - President of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) - Director of the Department of Public Health, Epidemiology and Health Economics at the University of Liège

Stuart Silverman, M.D., Ph.D.

- Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) - Director of the Cedars Sinai Bone Center of Excellence - Acting Chief of Rheumatology at West Los Angeles VA Medical Center

Stuart Silverman, M.D., Ph.D.

- Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) - Director of the Cedars Sinai Bone Center of Excellence - Acting Chief of Rheumatology at West Los Angeles VA Medical Center

Manju Chandran, M.D., Ph.D.

- Elected Member of the Board and of the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) - Chairperson, Asia Pacific Panel of the International Society of Clinical Densitometry (ISCD) - Chairperson, Asia Pacific Consortium on Osteoporosis (APCO) - Senior Consultant and Director, Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital - Clinical Professor, DUKE NUS Medical School

Manju Chandran, M.D., Ph.D.

- Elected Member of the Board and of the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) - Chairperson, Asia Pacific Panel of the International Society of Clinical Densitometry (ISCD) - Chairperson, Asia Pacific Consortium on Osteoporosis (APCO) - Senior Consultant and Director, Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital - Clinical Professor, DUKE NUS Medical School

Journey

2025

Received clearance from the Ministry of Korea Food and Drug Safety (MFDS) for PROS® CXR: OSTEO.

2024

Raised Series A2 investment.

Achieved the world’s highest AUC of 0.94.

Presented 15 abstracts at major conferences, including RSNA, KSBMR, ASBMR.

Designated as an innovative medical device by the MFDS.

Signed MOU with the Korean Society of Sarcopenia.

Sponsored the International Osteoporosis Foundation (IOF).

Joined PRECCO*, a 5-year collaboration between WHO, IOF, and ESCEO for industry-academia cooperation.

2023

Pivoted to AI software for chest X-ray-based osteoporosis diagnosis PROS® CXR: OSTEO.

Started research collaboration with Massachusetts General Hospital, Penn. State Health, Seoul National University Hospital, etc.

2022

Obtained 24 domestic and international patents.

Winner of the Startup Pitching Grand Prize at The 20th World Korean Business Convention.

2021

Raised Series A1 investment.

Received the Small Business Minister’s Award.

2020

Selected for the TIPS R&D program by the Ministry of SMEs and Startups.

2019

PROMEDIUS Corporation established.

PROMEDIUS Inc.

Address

13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Republic of Korea

Tel.

+82-2-423-8511

Linkedin

Contact Us

Privacy Policy

Copyright 2025 PROMEDIUS INC. All rights reserved.

PROMEDIUS Inc.

Address

13, Olympic-ro 35da-gil, Songpa-gu,

Seoul, Republic of Korea

Tel.

+82-2-423-8511

Linkedin

Contact Us

Privacy Policy

Copyright 2025 PROMEDIUS INC. All rights reserved.